Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses
暂无分享,去创建一个
[1] K. Jakobs,et al. Calcium signalling by G protein-coupled sphingolipid receptors in bovine aortic endothelial cells , 1996, Naunyn-Schmiedeberg's Archives of Pharmacology.
[2] Chunyi Zhang,et al. A role for Rho in receptor- and G protein-stimulated phospholipase C Reduction in phosphatidylinositol 4,5-bisphosphate by Clostridium difficile toxin B , 1996, Naunyn-Schmiedeberg's Archives of Pharmacology.
[3] K. Jakobs,et al. Differential calcium signalling by m2 and m3 muscarinic acetylcholine receptors in a single cell type , 1995, Naunyn-Schmiedeberg's Archives of Pharmacology.
[4] U. Kutay,et al. Biogenesis and nuclear export of ribosomal subunits in higher eukaryotes depend on the CRM1 export pathway , 2003, Journal of Cell Science.
[5] J. Milner,et al. p53 is a chromatin accessibility factor for nucleotide excision repair of DNA damage , 2003, The EMBO journal.
[6] J. Borowiec,et al. Stress-Dependent Nucleolin Mobilization Mediated by p53-Nucleolin Complex Formation , 2002, Molecular and Cellular Biology.
[7] Pier Giuseppe Pelicci,et al. Nucleophosmin regulates the stability and transcriptional activity of p53 , 2002, Nature Cell Biology.
[8] Yili Yin,et al. p53 stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products , 2002, Nature Cell Biology.
[9] U. Moll,et al. Nuclear degradation of p53 occurs during down‐regulation of the p53 response after DNA damage , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[10] M. Mann,et al. Directed Proteomic Analysis of the Human Nucleolus , 2002, Current Biology.
[11] J. Hiscox,et al. The nucleolus – a gateway to viral infection? , 2002, Archives of Virology.
[12] R. Iggo,et al. Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[13] P. Hainaut,et al. Genotoxic and non-genotoxic pathways of p53 induction. , 2001, Cancer letters.
[14] J. Weitzman. Light-induced apoptosis , 2001, Genome Biology.
[15] M. J. Moné,et al. Local UV‐induced DNA damage in cell nuclei results in local transcription inhibition , 2001, EMBO reports.
[16] D. Lane,et al. Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53. , 2001, Experimental cell research.
[17] P. Roussel,et al. Common and reversible regulation of wild-type p53 function and of ribosomal biogenesis by protein kinases in human cells , 2001, Oncogene.
[18] Lester F. Lau,et al. Evidence of p53-Dependent Cross-Talk between Ribosome Biogenesis and the Cell Cycle: Effects of Nucleolar Protein Bop1 on G1/S Transition , 2001, Molecular and Cellular Biology.
[19] H. O’Hagan,et al. Accumulation of soluble and nucleolar-associated p53 proteins following cellular stress. , 2001, Journal of cell science.
[20] K. Tsai,et al. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53 , 2000, Nature Cell Biology.
[21] L. Comai,et al. Repression of RNA Polymerase I Transcription by the Tumor Suppressor p53 , 2000, Molecular and Cellular Biology.
[22] M. Ljungman. Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress. , 2000, Neoplasia.
[23] J. D. Weber,et al. The ARF/p53 pathway. , 2000, Current opinion in genetics & development.
[24] D. Meek,et al. Mechanisms of switching on p53: a role for covalent modification? , 1999, Oncogene.
[25] T. David-Pfeuty. Potent inhibitors of cyclin-dependent kinase 2 induce nuclear accumulation of wild-type p53 and nucleolar fragmentation in human untransformed and tumor-derived cells , 1999, Oncogene.
[26] A. Levine,et al. P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[27] I. Grummt,et al. Cell cycle-dependent regulation of RNA polymerase I transcription: the nucleolar transcription factor UBF is inactive in mitosis and early G1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[28] G. Wahl,et al. A leucine‐rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking , 1999, The EMBO journal.
[29] P. Herrlich,et al. DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation , 1999, Oncogene.
[30] A. Budde,et al. p53 represses ribosomal gene transcription , 1999, Oncogene.
[31] F. Chen,et al. Inhibition of RNA polymerase II as a trigger for the p53 response , 1999, Oncogene.
[32] I. Grummt,et al. Cell cycle-dependent regulation of RNA polymerase I transcription : The nucleolar transcription factor UBF is inactive in mitosis and early G 1 , 1999 .
[33] A. Levine,et al. Nuclear Export Is Required for Degradation of Endogenous p53 by MDM2 and Human Papillomavirus E6 , 1998, Molecular and Cellular Biology.
[34] Kevin Ryan,et al. The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2 , 1998, The EMBO journal.
[35] P. Jordan,et al. Cisplatin inhibits synthesis of ribosomal RNA in vivo. , 1998, Nucleic acids research.
[36] Robert J White,et al. p53 is a general repressor of RNA polymerase III transcription , 1998, The EMBO journal.
[37] L. Donehower,et al. Murine tumor suppressor models. , 1998, Mutation research.
[38] L. Mullenders,et al. Impaired DNA repair capacity in skin fibroblasts from various hereditary cancer-prone syndromes. , 1998, Mutation research.
[39] J. Hauber,et al. Interaction of the HIV-1 rev cofactor eukaryotic initiation factor 5A with ribosomal protein L5. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[40] A. Levine,et al. Nucleo‐cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein , 1998, The EMBO journal.
[41] S. Takasawa,et al. Muscarinic Receptor-mediated Dual Regulation of ADP-ribosyl Cyclase in NG108-15 Neuronal Cell Membranes* , 1997, Journal of Biological Chemistry.
[42] T. Wieland,et al. Identification of G protein-coupled receptors potently stimulating migration of human transitional-cell carcinoma cells , 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.
[43] B. Wasylyk,et al. Transcription Abnormalities Potentiate Apoptosis of Normal Human Fibroblasts , 1997, Molecular medicine.
[44] David P. Lane,et al. Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo , 1997, Current Biology.
[45] J. Putney,et al. Role of the Cytoskeleton in Calcium Signaling in NIH 3T3 Cells , 1997, The Journal of Biological Chemistry.
[46] K. Mikoshiba. The InsP3 receptor and intracellular Ca2+ signaling , 1997, Current Opinion in Neurobiology.
[47] B. Fontoura,et al. Cytoplasmic p53 polypeptide is associated with ribosomes , 1997, Molecular and cellular biology.
[48] T. Kurosaki,et al. Genetic evidence for involvement of type 1, type 2 and type 3 inositol 1,4,5‐trisphosphate receptors in signal transduction through the B‐cell antigen receptor , 1997, The EMBO journal.
[49] J. Blaydes,et al. Tolerance of high levels of wild-type p53 in transformed epithelial cells dependent on auto-regulation by mdm-2 , 1997, Oncogene.
[50] C. Potten,et al. Inhibition by uridine but not thymidine of p53-dependent intestinal apoptosis initiated by 5-fluorouracil: evidence for the involvement of RNA perturbation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[51] A. Levine. p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.
[52] G. S. Johnson,et al. An Information-Intensive Approach to the Molecular Pharmacology of Cancer , 1997, Science.
[53] D. Evans,et al. Li-Fraumeni syndrome--a molecular and clinical review. , 1997, British Journal of Cancer.
[54] Yan Liu,et al. Heat shock disassembles the nucleolus and inhibits nuclear protein import and poly(A)+ RNA export. , 1996, The EMBO journal.
[55] Duane D. Miller,et al. A novel membrane receptor with high affinity for lysosphingomyelin and sphingosine 1‐phosphate in atrial myocytes. , 1996, The EMBO journal.
[56] M. Ljungman,et al. Blockage of RNA polymerase as a possible trigger for u.v. light-induced apoptosis. , 1996, Oncogene.
[57] M. Beaven. Calcium signalling: Sphingosine kinase versus phospholipase C? , 1996, Current Biology.
[58] L. Strong,et al. Analysis of genomic instability in Li-Fraumeni fibroblasts with germline p53 mutations. , 1996, Oncogene.
[59] K. Jalink,et al. Sphingosine‐1‐phosphate rapidly induces Rho‐dependent neurite retraction: action through a specific cell surface receptor. , 1996, The EMBO journal.
[60] J. Kinet,et al. Calcium mobilization via sphingosine kinase in signalling by the FcɛRI antigen receptor , 1996, Nature.
[61] G. Wahl,et al. A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. , 1996, Genes & development.
[62] D C Ward,et al. Inhibition of RNA polymerase II transcription causes chromatin decondensation, loss of nucleolar structure, and dispersion of chromosomal domains. , 1996, Experimental cell research.
[63] Y. Pommier,et al. RNA synthesis inhibitors alter the subnuclear distribution of DNA topoisomerase I. , 1996, Cancer research.
[64] Y. Qi,et al. Quantitation of the nucleophosmin/B23-translocation using imaging analysis. , 1996, Cancer letters.
[65] Chunyi Zhang,et al. Activation of a High Affinity G Protein-coupled Plasma Membrane Receptor by Sphingosine-1-phosphate (*) , 1996, The Journal of Biological Chemistry.
[66] S. Hakomori,et al. N,N-dimethylsphingosine inhibition of sphingosine kinase and sphingosine 1-phosphate activity in human platelets. , 1996, Biochemistry.
[67] J. Exton. Regulation of phosphoinositide phospholipases by hormones, neurotransmitters, and other agonists linked to G proteins. , 1996, Annual review of pharmacology and toxicology.
[68] A. Kristjuhan,et al. Protein p53 modulates transcription from a promoter containing its binding site in a concentration-dependent manner. , 1995, European journal of biochemistry.
[69] P. Hanawalt,et al. Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[70] E. Krebs,et al. Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells: spatial and temporal modulation of PDGF chemotactic signal transduction , 1995, The Journal of cell biology.
[71] H. Boddeke,et al. Heparin‐insensitive calcium release from intracellular stores triggered by the recombinant human parathyroid hormone receptor , 1995, British journal of pharmacology.
[72] S. Rhee,et al. Significance of PIP2 hydrolysis and regulation of phospholipase C isozymes. , 1995, Current opinion in cell biology.
[73] A. Levine,et al. The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes , 1994, Molecular and cellular biology.
[74] T. Sugano,et al. U.v.-induced nuclear accumulation of p53 is evoked through DNA damage of actively transcribed genes independent of the cell cycle. , 1994, Oncogene.
[75] D. Gill,et al. Sphingosine 1-phosphate generated in the endoplasmic reticulum membrane activates release of stored calcium. , 1994, The Journal of biological chemistry.
[76] T. Graeber,et al. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status , 1994, Molecular and cellular biology.
[77] S. Spiegel,et al. Stereospecificity of sphingosine-induced intracellular calcium mobilization and cellular proliferation. , 1994, The Journal of biological chemistry.
[78] S. Spiegel,et al. Sphingosine-1-phosphate, a putative second messenger, mobilizes calcium from internal stores via an inositol trisphosphate-independent pathway. , 1994, The Journal of biological chemistry.
[79] K. Ghoshal,et al. Specific inhibition of pre-ribosomal RNA processing in extracts from the lymphosarcoma cells treated with 5-fluorouracil. , 1994, Cancer research.
[80] S. Spiegel,et al. Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens , 1993, Nature.
[81] P. Hanawalt,et al. Lack of transcription-coupled repair in mammalian ribosomal RNA genes. , 1993, Biochemistry.
[82] P. Vigne,et al. ADP induces inositol phosphate-independent intracellular Ca2+ mobilization in brain capillary endothelial cells. , 1993, The Journal of biological chemistry.
[83] M. Berridge. Inositol trisphosphate and calcium signalling , 1993, Nature.
[84] S. Cockcroft,et al. Inositol-lipid-specific phospholipase C isoenzymes and their differential regulation by receptors. , 1992, The Biochemical journal.
[85] B. Fontoura,et al. p53 is covalently linked to 5.8S rRNA , 1992, Molecular and cellular biology.
[86] R. Bell,et al. Inhibition of sphingosine kinase in vitro and in platelets. Implications for signal transduction pathways. , 1992, The Journal of biological chemistry.
[87] B. Yung,et al. Nucleolar protein B23 translocation after deferoxamine treatment in a human leukemia cell line , 1991, International journal of cancer.
[88] R. Carroll,et al. The tumor suppressor p53 is bound to RNA by a stable covalent linkage , 1991, Molecular and cellular biology.
[89] D. Gill,et al. Intracellular calcium release mediated by sphingosine derivatives generated in cells. , 1990, Science.
[90] S. Hakomori,et al. Effect of chemically well-defined sphingosine and its N-methyl derivatives on protein kinase C and src kinase activities. , 1989, Biochemistry.
[91] H. Motulsky,et al. Alpha 2-adrenergic receptor stimulation mobilizes intracellular Ca2+ in human erythroleukemia cells. , 1989, The Journal of biological chemistry.
[92] Y. Chentsov,et al. Ultrastructural changes in nucleoli and fibrillar centers under the effect of local ultraviolet microbeam irradiation of interphase culture cells. , 1989, Experimental cell research.
[93] M. Berridge,et al. Subsecond and second changes in inositol polyphosphates in GH4C1 cells induced by thyrotropin-releasing hormone. , 1987, The Biochemical journal.
[94] J. Pédron,et al. Ultrastructural and autoradiographic study of the effects of bleomycin on the interphase nucleus of cultured normal cells. , 1979, Cancer research.
[95] I. T. Young. Proof without prejudice: use of the Kolmogorov-Smirnov test for the analysis of histograms from flow systems and other sources. , 1977, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[96] A. Kisic,et al. Sphingolipid base metabolism. Partial purification and properties of sphinganine kinase of brain. , 1976, The Journal of biological chemistry.
[97] F. Grummt,et al. Control of nucleolar RNA synthesis by the intracellular pool sizes of ATP and GTP , 1976, Cell.